Neonatal Clinical Trials 1

559 - Three-year mortality and disability in very preterm and low birthweight infants cared for in single family rooms versus open bay units: Randomized Controlled Trial

560 - Association of Trial Enrollment with 22–26-month Corrected Age Outcomes in Extremely Preterm Infants: A Retrospective Cohort Study

561 - Evaluating the Impact of Bowel Ultrasound on Patient Outcomes in Suspected NEC: A Multisite Randomized Diagnostic Trial

562 - A Randomized Controlled Trial of Ultrasound-Assisted Versus Traditional Landmark Lumbar Puncture in the Neonatal and Infant Population

563 - Respiratory Morbidity in Extremely Preterm Infants Randomized to Receive either Early or Delayed Human Milk Fortification: A Secondary Analysis

564 - Essential Fatty Acid Deficiency and Liver Disease in Pediatric Patients: A Double Blind, Randomized, Controlled Trial Comparing Olive Oil-Based Versus Soybean Oil-Based Lipid Emulsions

552 - Prevalence of Intraventricular Hemorrhage in an RCT of Ventilation During Delayed Cord Clamping: A Subanalysis of the VentFirst Trial

553 - Extreme Preterm Infant Non-Invasive Surfactant Trial (EPINIST) – a Pilot RCT

554 - Selective Early Medical Treatment of the Patent Ductus Arteriosus (PDA) in Extremely Low Gestational Age Infants: A Pilot Randomized Controlled Trial (the SMART PDA RCT)

555 - Exploring the role of sildenafil in brain metabolite concentrations recovery in neonates with hypoxic-ischemic brain injury during the first month of life

556 - A Multicenter Randomized, Blinded Trial of Weaning Opioids for Neonatal Opioid Withdrawal Syndrome

557 - External Validation of a Caffeine Population Pharmacokinetic Model in Infants with Congenital Heart Disease using Pragmatic Trial Design

558 - The Outcomes of Anakinra Pilot - A First-in-Population Clinical Trial Assessing Safety, Feasibility and Pharmacokinetics of IL-1 Receptor Antagonist in Preterm Infants